Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I
| Status: | Recruiting |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/11/2019 |
| Start Date: | March 2016 |
| End Date: | February 2020 |
| Contact: | Ashley Sanders, BA |
| Email: | ashley.sanders@yale.edu |
| Phone: | (203) 932-5711 |
The overall purpose of this study is to examine the effect of Pregnenolone (PREG) on the
acute psychosis-like and cognitive effects of Delta-9-Tetrahydrocannabinol (THC). This will
be tested by pretreating healthy individuals with PREG, and then assessing their responses to
Dronabinol (THC).
acute psychosis-like and cognitive effects of Delta-9-Tetrahydrocannabinol (THC). This will
be tested by pretreating healthy individuals with PREG, and then assessing their responses to
Dronabinol (THC).
Inclusion Criteria:
- Exposed to cannabis at least once in lifetime
Exclusion Criteria:
- Cannabis naïve
- Individuals with a documented reaction/allergy to Pregnenolone
- Individuals with a documented reaction/allergy to Sesame oil
We found this trial at
1
site
West Haven, Connecticut 06516
Principal Investigator: Deepak Cyril D'Souza, MD
Phone: 203-932-5711
Click here to add this to my saved trials
